Beta Drugs Limited — Board Meeting, 19-10-2024: Outcome of Board Meeting

Beta Drugs Limited's Board has approved increasing the authorized share capital and plans to issue equity shares and compulsorily convertible debentures (CCDs) on a preferential basis. An extraordinary general meeting is scheduled for November 12, 2024, to seek shareholder approval for these matters. Three investors are involved, with CCDs convertible into equity shares after six months. The meeting aims to pass resolutions regarding these changes and grant special rights to certain investors.